Anti-leishmanial Effects of Trinitroglycerin in BALB/C Mice Infected with Leishmania major via Nitric Oxide Pathway
![]() ![]() |
Nahrevanian, Hossein
(Department of Parasitology, Pasteur Institute of Iran)
Najafzadeh, Mana (Payame Nour University, Tehran Centre Unit) Hajihosseini, Reza (Payame Nour University, Tehran Centre Unit) Nazem, Habib (Payame Nour University, Tehran Centre Unit) Farahmand, Mahin (Department of Parasitology, Pasteur Institute of Iran) Zamani, Zahra (Department of Biochemistry, Pasteur Institute of Iran) |
1 | Scott PH. Immunologic memory in cutaneous leishmaniasis. Cell Microbiol 2005; 7: 1707-1713 DOI PUBMED ScienceOn |
2 | Stebut E. Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 2007; 17: 115-122 DOI ScienceOn |
3 | Colassanti M, Gradani L, Mattu M, Persichini T, Salvati L, Venturini G, Ascenzi P. Molecular bases for the anti-parasitic effect of NO (review). Int J Mol Med 2002; 9: 131-134 PUBMED ScienceOn |
4 | Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, Vincendeau P, Lemesre JL. Nitric oxide-mediated proteasomedependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immunol 2002; 70: 3727-3735 DOI ScienceOn |
5 | Jaafari MR, Behravan J, Bodagh Abadi A, Ramezani M. Evaluation of leishmanicidal effect of Euphorbia myrsinites extract by in vitro antileishmanial assay using promastigote of Leishmania major. Iranian J Basic Med Sc 2005; 8: 295-298 |
6 | El-On J, Witztum A, Schnur LF. Protection of Guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy. Infec Immun 1986; 51: 704-706 PUBMED |
7 | Nahrevanian H, Gholizadeh SJ, Farahmand M, Aghighi Z, Assmar M, Abolhassani M. Reactive nitrogen intermediate production and tolerance variability in different mouse strains after in vivo treatment with lipopolysaccharide from Salmonella abortus equi. J Microbiol Immunol Infec 2005; 38: 164-168 |
8 | Nahrevanian H, Dascombe MJ. Nitric oxide and reactive nitrogen intermediates during lethal and non-lethal strains of murine malaria. Parasite Immunol 2001; 23: 491-501 DOI ScienceOn |
9 | Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi E, Modabber F. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol 2003; 134: 303-308 DOI ScienceOn |
10 |
Spahl UD, Berendji-Grun D, Suschek VB, Kolb-Bachofen V, Kroncke C. Regulation of zinc homeostasis by inducible NO synthasederived NO: nuclear metallothionein translocation and intranuclear |
11 | Mossalayi MD, Arock M, Mazier D, Vincendeau P, Vouldoukis I. The human immune response during cutaneous leishmaniasis: no problem. Parasitol Today 1999; 15: 342-345 DOI ScienceOn |
12 | Nahrevanian H, Dascombe MJ. Reactive nitrogen intermediate (RNI) levels inside and outside Plasmodium infected red blood cells in murine malaria. J Trop Med Parasitol 2003; 26: 13-19 |
13 | Giudice A, Camada I, Leopoldo PTG, Pereira JMB, Riley LW, Wilson ME, Ho JL, de Jesus AR, Carvalho EM, Almeida RP. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in tegumentary leishmaniasis. BMC Infec Dis 2007; 7: 7 DOI ScienceOn |
14 | Khalid AF, Abdalla MN, Mohomed OH, Toum AM, Magzoub MA, Siddig MA. In vitro assessment of anti-cutaneous leishmaniasis activity of some sudanese plants. Turkiye Parazitoloji Dergisi 2005; 29: 3-6 |
15 | Salih Gurel M, Ulukanligil M, Ozbilge H. Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000). Int J Dermatol 2002; 41: 32-37 DOI ScienceOn |
16 | Erel O, Kocyigit A, Bulut V, Gurel M. Reactive nitrogen and oxygen intermediates in patients with cutaneouse leishmaniasis. Mem Inst Osw Cruz 1999; 94: 179-183 DOI PUBMED ScienceOn |
17 | Kolaczinski J, Brooker S, Reyburn H, Rowland M. Epidemiology of anthroponotic cutaneous leishmaniasis in Afghan refugee camps in North-West Pakistan. Trans R Soc Trop Med Hyg 2004; 98: 373-378 DOI PUBMED ScienceOn |
18 | Nahrevanian H, Farahmand M, Aghighi Z, Assmar A, Amirkhani A. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in BALB/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis. Exp Parasitol 2007; 116: 233-240 DOI ScienceOn |
19 | Kharazi SH, Zavaran Hosseini A, Tiraihi T. The role of overproduction of nitric oxide in apoptosis of BALB/c mice macrophages infected with Leishmania major in vitro. Iranian J Allerg Asthm Immunol 2003; 2: 209-214 |
20 | Faryadi M, Mohebali M. Alterations of serum zinc, copper and iron concentrations in patients with acute and chronic cutaneous leishmaniasis. Iranian J Publ Health 2003; 32: 53-58 |
21 | Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, Vincendeau P, Lemesre J. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immunol 2002; 70: 3727-3735 DOI ScienceOn |
22 | Zeina B, Banfield C, Assad SA. Topical glycerine trinitrate: a possible treatment for cutaneouse leishmaniasis. Clin Exp Dermatol 1997; 22: 244-245 DOI ScienceOn |
23 | Megson LI. Nitric oxide donor drugs. Drug Future 2000; 25: 701-715 DOI |
24 | Nassiri-Kashani M, Firooz A, Khamesipour A, Mojtahed F, Nilforoushzadeh M, Hejazi H, Bouzari N, Dowlati Y. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. J Eur Acad Dermatol Venereol 2005; 19: 80-83 DOI ScienceOn |
25 | Croft S, Seifert K, Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006; 123: 399-410 ScienceOn |
![]() |